Corbus Pharmaceuticals Holdings Inc is a clinical stage biopharmaceutical company. The Company is focused on the development and commercialization of novel therapeutics to treat rare, life-threating inflammatory-fibrotic diseases.
| Website: | www.corbuspharma.com |
| Main Phone: | +1 617 963-0100 |
| Address: | 100 River Ridge Drive |
| Address 2: | Suite 103 |
| State: | MA |
| City / Town: | Norwood |
| Country: | USA |
| Postal Code: | 02062 |
| Exchange: | NSC |
| Employees: | 12 |
| NAICS: | Biological Produ |
| Last Price 5.90 | Change $ -0.1 | Change % -1.67 | Tick N/A |
| Bid 5.90 | Bid Size 900.00 | Ask 6.10 | Ask Size 1,800.00 |
| Open 5.95 | High 6.10 | Low 5.90 | Prev Close 6.00 |
| Last Trade | Volume 221,489 | 52 Wk Hi 10.78 | 52 Wk Low 3.50 |
| Market Cap 296.3 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 50,220,510.00 | EPS (TTM) -0.61 | PE Ratio N/A | Exchange NSD |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 6.25 | 6.25 | 6.25 | 7 |
| Low Target Price Estimate | 6 | 6 | 6 | 6 |
| Mean Target Price Estimate | 6.08 | 6.08 | 6.08 | 6.31 |
| Standard Deviation | 0.14 | 0.14 | 0.14 | 0.47 |
| Date of Most Recent Estimate | 08/15/16 | 06/16/16 | 06/16/16 | 08/21/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-26 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-22 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-18 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-18 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-18 |
| 8-K | Report of unscheduled material events or corporate changes. | 12 | 2016-08-15 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 34 | 2016-08-12 |
| 8-K | Report of unscheduled material events or corporate changes. | 41 | 2016-06-16 |
| 424B5 | Prospectus filed under Rule 424(b)(5) | 78 | 2016-06-13 |
| 8-K | Report of unscheduled material events or corporate changes. | 29 | 2016-06-10 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
